Home > Insider Trading > Filing (0001628280-24-049400)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1157601	Madrigal Pharmaceuticals Inc.	MDGL	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1014095	B Fred Craves	C/O Bay City Capital Llc, 1000 4Th Street, Suite 500 San Rafael CA 94901		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2024-11-25	2,200	$350.08	15,800	No	4	S	Indirect	See Footnotes
Common Stock	Disposition	2024-11-25	1,200	$350.71	14,600	No	4	S	Indirect	See Footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnotes
No	4	S	Indirect	See Footnotes

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	360,076	Direct
Common Stock	11,210	Indirect	See Footnote
Common Stock	1,261	Indirect	See Footnotes

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $350.00 to $350.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.
Represents shares held indirectly by Dr. Craves through the Craves Family Foundation.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $350.46 to $351.06, inclusive.
Represents shares held indirectly by Dr. Craves through a grantor retained annuity trust.
These securities are held by Bay City Capital LLC ("BCC"). Dr. Craves disclaims beneficial ownership of these securities held by BCC, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such shares, except to the extent of his pecuniary interest, if any, in the securities by virtue of the limited liability company interests he owns in BCC.